ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02041533
Brief Title: An Open-Label, Randomized, Phase 3 Trial of Nivolumab Versus Investigator's Choice Chemotherapy as First-Line Therapy for Stage IV or Recurrent PD-L1+ Non-Small Cell Lung Cancer (CheckMate 026)

First Submitted : January 19, 2014
First Submitted that Met QC Criteria : January 19, 2014
First Posted : January 22, 2014 (Estimate)

Results First Submitted : June 26, 2017
Results First Submitted that Met QC Criteria : June 26, 2017
Results First Posted : July 26, 2017

Last Update Submitted that Met QC Criteria : January 18, 2018
Last Update Posted : February 14, 2018